These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

449 related items for PubMed ID: 12715885

  • 1. HIV-1 TAR as anchoring site for optimized catalytic RNAs.
    Puerta-Fernandez E, Barroso-del Jesus A, Romero-López C, Berzal-Herranz A.
    Biol Chem; 2003 Mar; 384(3):343-50. PubMed ID: 12715885
    [Abstract] [Full Text] [Related]

  • 2. Anchoring hairpin ribozymes to long target RNAs by loop-loop RNA interactions.
    Puerta-Fernández E, Barroso-DelJesus A, Berzal-Herranz A.
    Antisense Nucleic Acid Drug Dev; 2002 Feb; 12(1):1-9. PubMed ID: 12022685
    [Abstract] [Full Text] [Related]

  • 3. The antisense sequence of the HIV-1 TAR stem-loop structure covalently linked to the hairpin ribozyme enhances its catalytic activity against two artificial substrates.
    Pérez-Ruiz M, Sievers D, García-López PA, Berzal-Herranz A.
    Antisense Nucleic Acid Drug Dev; 1999 Feb; 9(1):33-42. PubMed ID: 10192287
    [Abstract] [Full Text] [Related]

  • 4. Ribozyme targeting of HIV-1 LTR.
    Ventura M, Wang P, Franck N, Saragosti S.
    Biochem Biophys Res Commun; 1994 Sep 15; 203(2):889-98. PubMed ID: 8093072
    [Abstract] [Full Text] [Related]

  • 5. Cleavage of the highly conserved hairpin-loop region of HIV-1 by synthetic ribozymes.
    Shimayama T, Nishikawa S, Taira K.
    Nucleic Acids Symp Ser; 1993 Sep 15; (29):177-8. PubMed ID: 8247758
    [Abstract] [Full Text] [Related]

  • 6. Kinetic selectivity of complementary nucleic acids: bcr-abl-directed antisense RNA and ribozymes.
    Kronenwett R, Haas R, Sczakiel G.
    J Mol Biol; 1996 Jun 21; 259(4):632-44. PubMed ID: 8683570
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Construction of new ribozymes requiring short regulator oligonucleotides as a cofactor.
    Komatsu Y, Yamashita S, Kazama N, Nobuoka K, Ohtsuka E.
    J Mol Biol; 2000 Jun 23; 299(5):1231-43. PubMed ID: 10873448
    [Abstract] [Full Text] [Related]

  • 10. Antisense RNA sequences targeting the 5' leader packaging signal region of human immunodeficiency virus type-1 inhibits viral replication at post-transcriptional stages of the life cycle.
    Chadwick DR, Lever AM.
    Gene Ther; 2000 Aug 23; 7(16):1362-8. PubMed ID: 10981662
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Inhibition of HIV-1 replication by RNA targeted against the LTR region.
    Puerta-Fernández E, Barroso-del Jesus A, Romero-López C, Tapia N, Martínez MA, Berzal-Herranz A.
    AIDS; 2005 Jun 10; 19(9):863-70. PubMed ID: 15905666
    [Abstract] [Full Text] [Related]

  • 13. Structure and function of the hairpin ribozyme.
    Fedor MJ.
    J Mol Biol; 2000 Mar 24; 297(2):269-91. PubMed ID: 10715200
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A three-nucleotide helix I is sufficient for full activity of a hammerhead ribozyme: advantages of an asymmetric design.
    Tabler M, Homann M, Tzortzakaki S, Sczakiel G.
    Nucleic Acids Res; 1994 Sep 25; 22(19):3958-65. PubMed ID: 7937118
    [Abstract] [Full Text] [Related]

  • 17. Length variation of helix III in a hammerhead ribozyme and its influence on cleavage activity.
    Hammann C, Martinez E, Moosbauer J, Hormes R, Tabler M.
    Antisense Nucleic Acid Drug Dev; 1999 Feb 25; 9(1):25-31. PubMed ID: 10192286
    [Abstract] [Full Text] [Related]

  • 18. Efficient hammerhead ribozyme and antisense RNA targeting in a slow ribosome Escherichia coli mutant.
    Chen H, Ferbeyre G, Cedergren R.
    Nat Biotechnol; 1997 May 25; 15(5):432-5. PubMed ID: 9131620
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Exploring the use of antisense, enzymatic RNA molecules (ribozymes) as therapeutic agents.
    Rossi JJ, Elkins D, Taylor N, Zaia J, Sullivan S, Deshler JO.
    Antisense Res Dev; 1991 May 25; 1(3):285-8. PubMed ID: 1821650
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.